Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (256)	11/22/1998 8:48:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

Jim: Yup, I attended. Can't believe the quality of the forums, given that they cost about the same as a good lunch. What do you want to know? The speaker was Christopher Searcy. Took shots at ARDM, emphasizing that there was no issue with breath coordination..... single breath, due to high concentration of drug/breath. ARDM turned the tables and pointed at the simplicity of their licensing agreement, indicating that they'd have the pricing advantage. Phase III program kicked off two weeks ago, also emphasized that there was no safety issues with "regulatory" to date. Deals structured to give INHL gross profits of 8-14%, expect seven programs in clinical testing within 12 months. One product partnered but not announced?? Cheers! Rick